First Draft Of WHO’s Pandemic Treaty: IP Waivers, Tech Transfer & Price Transparency
A World Health Organization negotiating body will shortly examine the “zero draft” of a proposed pandemic treaty aimed at better preparing the world for future health crises. But the international pharmaceutical industry claims the draft as currently worded could actually undermine equitable access to pandemic countermeasures.
You may also be interested in...
Clash Looms Over IP Proposals As WHO's Draft Pandemic Treaty Moves Forward
Measures to relax intellectual property protections are put forward in the “zero draft” of the World Health Organization's future pandemic treaty as well as in proposed amendments to the International Health Regulations, which describe how countries can prepare for and respond to health emergencies.
Countries To Discuss Pandemic Treaty Next Year Amid Industry Concern
A World Health Organization negotiating body has agreed to develop a “zero draft” of the proposed pandemic treaty for discussion at a meeting of WHO member states in February next year. But the international pharmaceutical industry has reiterated its concerns about some of the proposals being put forward.
WHO’s Draft Pandemic Treaty Calls For More Regulatory Harmonization
Regulatory convergence and the sharing of dossiers, together with the timely and equitable sharing of pathogens, could help to speed up access to diagnostics, vaccines and medications in pandemic situations, according to the first draft of the World Health Organization’s proposed pandemic treaty.